Details of the Drug Formulaction

General Information of Drug Formulation (ID: F00001)

• Formulation Name: Dalfampridine 10 mg tablet
• Company: Acorda Therapeutics

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Dalfampridine	(DMM0PDO)	Multiple sclerosis	8A40	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent